subscribeSubscribe
FDA Confirms Paragraph IV Patent Litigation for Galafold (Migalastat Hydrochloride)

FDA Confirms Paragraph IV Patent Litigation for Galafold (Migalastat Hydrochloride)
FDA
03 Oct 2022
Share Share
Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold

Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold
GLOBENEWSWIRE
19 Apr 2022
Share Share
Amicus spins off gene therapy unit in $600M SPAC deal

Amicus spins off gene therapy unit in $600M SPAC deal
Ben Adams FIERCEBIOTECH
30 Sep 2021
Share Share
Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021

Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021
Phil Taylor PHARMAPHORUM
13 Aug 2020
Share Share
Amicus, Penn expand gene therapy research agreement into five-year collaboration

Amicus, Penn expand gene therapy research agreement into five-year collaboration
Natalie Grover ENDPTS
30 May 2019
Share Share
2018 Drug Approvals: A Closer Look

2018 Drug Approvals: A Closer Look
Derek Lowe SCIENCE MAG BLOG
05 Feb 2019
Share Share
Orphan drugs from Biogen and Amicus win UK Prix Galien

Orphan drugs from Biogen and Amicus win UK Prix Galien
Andrew McCg PM LIVE
17 Nov 2018
Share Share
FDA Approves Eight Novel Drugs in August

FDA Approves Eight Novel Drugs in August
Alex Keown BIOSPACE
03 Sep 2018
Share Share
FDA Approves Galafold (migalastat) for Fabry Disease

FDA Approves Galafold (migalastat) for Fabry Disease
CNBC
11 Aug 2018
Share Share
New management offers Amicus a warm embrace and marketing OK for Galafold

New management offers Amicus a warm embrace and marketing OK for Galafold
John Carroll ENDPTS
10 Aug 2018
Share Share